United States · FDA National Drug Code directory
Seysara
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16110-247_4f9be4df-4e12-4f08-8e6f-cb07926ea5e6
- Product NDC
- 16110-247
- Form
- TABLET, COATED
- Composition / generic term
- sarecycline hydrochloride
- Labeler
- Almirall, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190104
- Source listing expiry
- 20261231
Source-listed ingredients
- SARECYCLINE HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (16110-247-30) · 16110-247-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →